This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN slumped 0.38% to $2.62 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.21% to 4,072.43 and the Dow Jones Industrial Average DJIA rising 1.03% to 32,529.63. Ocugen Inc. closed $15.03 below its 52-week high ($17.65), which the company reached on November 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Adverum Biotechnologies Inc. ADVM fell 3.73% to $1.55, Ocular Therapeutix Inc. OCUL fell 3.37% to $4.30, and Kodiak Sciences Inc. KOD rose 1.02% to $9.89. Trading volume (4.1 M) remained 2.3 million below its 50-day average volume of 6.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 28, 2022.
(END) Dow Jones Newswires
July 28, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.